论著摘要 |【多模态】RCC成像中的挑战:肾功能不全,手术后监测以及影像学的作用(双语版)

2017-12-28 14:37:13 admin 0

Challenges in RCC Imaging: Renal Insufficiency, Post-Operative Surveillance, and the Role of Radiomics.

发表日期: 2015.11   来源:Kidney Cancer Journal. 2015 Nov; 13(4): 84–90.

作者:

Nicholas J Farber1, Yan Wu2,3 , Lily Zou3, Puneet Belani3, and Eric A Singer1,2.

作者介绍:

1. Rutgers Robert Wood Johnson Medical School, Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, Room 4563 New Brunswick, NJ 08903, USA

2. Center for Biomedical Imaging & Informatics, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, 195 Little Albany Street, New Brunswick, NJ 08903, USA

3. Rutgers Robert Wood Johnson Medical School, Department of Radiology, MEB #404 P.O. Box 19, New Brunswick, NJ 08903, USA

摘要

肾细胞癌(RCC)是泌尿生殖系统第三大常见癌症,2015年将在美国估计61,560例新发病例和14,080例死亡病例。1.过去几十年来,RCC的发病率每年都稳步上升了大约2-4%。2. 从术前到术后的监测,影像学在肾脏病患者的评估和管理中起了决定性的作用。不幸的是,在临床实践中,泌尿科医师经常面临成像困难,缺乏明确的答案。在这里,我们探讨当前成像主题背后的现有数据,包括对肾功能不全的患者进行成像,建立RCC治疗后的监测方案,最大限度地减少监测期间的放射治疗以及新出现的成像趋势。

Abstact

Renal cell carcinoma (RCC) is the third most common cancer of the genitourinary system and in 2015 will account for an estimated 61,560 new cases and 14,080 deaths in the United States 1. Over the past several decades, the incidence of RCC has risen steadily by approximately 2-4% annually 2. Imaging plays an integral role in the evaluation and management of a patient with a renal mass, from the preoperative workup to the postoperative surveillance. Unfortunately, in clinical practice the urologist is often faced with imaging dilemmas that lack definitive answers. Herein we explore the current data behind contemporary imaging topics, including imaging a patient with renal insufficiency, establishing a surveillance protocol after RCC therapy, minimizing radiation therapy during surveillance, and emerging imaging trends.

关键词:

肾透明细胞癌影像,弥散MRI,肾癌监测,分子成像,灌注MRI,辐射照射

Keywords:

Renal cell carcinoma imaging; diffusion MRI; kidney cancer surveillance; molecular imaging; perfusion MRI; radiation exposure

阅读原文:PMID: 26937265  PMCID: PMC4770557


慧影医疗科技(北京)有限公司

地点:北京市海淀区中关村东升科技园B2-C103

电话:400-890-9020

邮箱:radcloud@huiyihuiying.com

关闭
图片
图片